At face value without knowing the detail this would appear to be a very good deal for Opthea. You have company that is prepared to stump in up to $170 million which if Opt-302 is not commercialised they will by all accounts have lost their dosh. In addition Carlyle is not doing to get any return on their investment for at least 3 years. Aside from inflation devaluing their return with a 7% licensing fee Opthea will have to have sales of close to $10 billion for the Carlyle to maximise it’s return on their investment and this is not going to happen overnight. As a shareholder if Opthea achieves earnings in the billions I will be a very happy man. In my opinion the Carlyle deal represents significant validation for Opthea. It will be interesting to see how the market reacts.
- Forums
- ASX - By Stock
- OPT
- Ann: Trading Halt
Ann: Trading Halt, page-25
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
49.5¢ |
Change
0.005(1.02%) |
Mkt cap ! $609.3M |
Open | High | Low | Value | Volume |
48.5¢ | 50.5¢ | 46.5¢ | $690.9K | 1.420M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1264 | 49.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 15502 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 0.500 |
4 | 6105 | 0.495 |
4 | 42394 | 0.475 |
3 | 16767 | 0.470 |
1 | 4000 | 0.465 |
Price($) | Vol. | No. |
---|---|---|
0.510 | 3980 | 1 |
0.520 | 43201 | 4 |
0.550 | 63528 | 4 |
0.555 | 190476 | 1 |
0.560 | 9000 | 1 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |